Evaluation of the Pulmonary Fibrosis Learning and Self-management Programme (FILIP)

Recruiting N/A Interventional Study
Lung Fibrosis Interstitial
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
80 (estimated)
Sponsor
Insel Gruppe AG, University Hospital Bern · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this observational study is to evaluate the feasibility and acceptability of a newly developed digital education and self-management program for people with fibrotic interstitial lung diseases (FILD) during inpatient pulmonary rehabilitation and outpatient interstitial lung disease (ILD) care. The study also explores whether participation in the program is associated with changes in he…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion criteria are: * Diagnosis of a FILD as major indication for pulmonary rehabilitation (for Berner Reha Zentrum only) * Enrolled in Idiopathic interstitial Pneumonia (IIP) cohort study (Nr. 246/15 / PB\_2016-01524) and agreed to further use of data for further research purpose (for Inselspi…
Contacts

Thimo Marcin, PhD

+41 33 244 3048

thimo.marcin@rehabern.ch

CONTACT

Thomas Franz Riegler, PhD

+41 (0) 58 934 64 06

thomas.riegler@zhaw.ch

CONTACT